Stoke Therapeutics Assumed With an Outperform at Leerink

Yahoo FinanceOct 13 06:10

Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases

Yahoo FinanceOct 12 22:18

Leerink Partners Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Cuts Target Price to $18

Futu NewsOct 12 06:31 · Ratings

Stoke Therapeutics Files Mixed Shelf

MT NewswiresOct 10 05:16

Express News | Stoke Therapeutics Inc - Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing

BreakingsOct 10 04:18

We're Hopeful That Stoke Therapeutics (NASDAQ:STOK) Will Use Its Cash Wisely

Simply Wall StSep 25 19:20